Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
Final Decision from European Commission Expected by Mid-2008 COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24 /PRNewswire/ - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the…
Tags: wirRelated posts